Barclays lowered the firm’s price target on Acadia Healthcare (ACHC) to $43 from $76 and keeps an Overweight rating on the shares. The company noted about $50M in startup costs next year, which was higher than expectations and offsets a meaningful portion of the Tennessee SDP, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $64 from $94 at RBC Capital
- Acadia Healthcare price target lowered to $70 from $91 at TD Cowen
- Acadia Healthcare price target lowered to $45 from $75 at Deutsche Bank
- Acadia Healthcare Reports Strong Q3 2024 Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats